[EN] INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DE NOROVIRUS ET DE CORONAVIRUS
申请人:COCRYSTAL PHARMA INC
公开号:WO2021206876A1
公开(公告)日:2021-10-14
Compounds of Formula (I) and methods of inhibiting the replication of viruses in a biological sample or patient, of reducing the amount of viruses in a biological sample or patient, and of treating a virus infection in a patient, comprising administering to said biological sample or patient an effective amount of a compound represented by Formula (I), a compound of Table A or B or a pharmaceutically acceptable salt thereof.
The present invention relates to compounds of the general formula (I)
in which Q, V, T, W, X, Y and A have the meanings given in the description—and to their use for controlling animal pests.
本发明涉及一般式(I)中Q、V、T、W、X、Y和A所表示的化合物,以及它们用于控制动物害虫的用途。
Pd(II)‐Catalyzed Asymmetric Addition of Arylboronic Acids to Aliphatic
<i>N</i>
‐Carbamoyl Hydrazones
作者:Saúl Alberca、Marta Velázquez、José Trujillo‐Sierra、Javier Iglesias‐Sigüenza、Rosario Fernández、José M. Lassaletta、David Monge
DOI:10.1002/adsc.202200430
日期:2022.7.19
ligands have been applied to 1,2 addition of arylboronic acids to aliphatic N-carbamoyl (Cbz) hydrazones, affording protected α-aryl monoalkylhydrazines with high enantioselectivities (37-99% ee). Subsequent removal of the benzyloxy carbonyl protectinggroup provides a direct entry to free monosubstituted hydrazines, key building blocks for the synthesis of appealing 1,2-diaza-heterocycles, aminoacid derived
The present invention relates to compounds of the general formula (I)
in which Q, V, T, W, X, Y and A have the meanings given in the description—and to their use for controlling animal pests.
本发明涉及通式 (I) 的化合物
中 Q、V、T、W、X、Y 和 A 的含义,以及它们在控制动物害虫方面的用途。